Across carcinomas, tumor-retained CCR7+ migratory dendritic cells downregulate antigen-presentation programs with dwell time, implying that retention within the tumor parenchyma diminishes cross-priming potential (68, 69). The gene discussed is CCR7; the disease is neoplasm.